![]() | |
Names | |
---|---|
IUPAC name
2-[2-[(E)-(Pyridine-4-carbonylhydrazinylidene)methyl]phenoxy]acetic acid
| |
Other names
Isonicophen; Phenoxalid
| |
Identifiers | |
3D model (
JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C15H13N3O4 | |
Molar mass | 299.286 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Aconiazide is an anti- tuberculosis medication. It is a prodrug of isoniazide that was developed and studied for its lower toxicity, [1] [2] but it does not appear to be marketed anywhere in the world in 2021.
![]() | |
Names | |
---|---|
IUPAC name
2-[2-[(E)-(Pyridine-4-carbonylhydrazinylidene)methyl]phenoxy]acetic acid
| |
Other names
Isonicophen; Phenoxalid
| |
Identifiers | |
3D model (
JSmol)
|
|
ChEMBL | |
ChemSpider | |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C15H13N3O4 | |
Molar mass | 299.286 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Aconiazide is an anti- tuberculosis medication. It is a prodrug of isoniazide that was developed and studied for its lower toxicity, [1] [2] but it does not appear to be marketed anywhere in the world in 2021.